[HTML][HTML] Childhood cancer: occurrence, treatment and risk of second primary malignancies

S Zahnreich, H Schmidberger - Cancers, 2021 - mdpi.com
Simple Summary Childhood cancers are mostly of unknown etiology and represent
devastating diagnoses. The clinical benefits of steadily increasing tumor control and survival …

The intrinsic and microenvironmental features of diffuse midline glioma: implications for the development of effective immunotherapeutic treatment strategies

ML Persson, AM Douglas, F Alvaro, P Faridi… - Neuro …, 2022 - academic.oup.com
Diffuse midline glioma (DMG), including those of the brainstem (diffuse intrinsic pontine
glioma), are pediatric tumors of the central nervous system (CNS). Recognized as the most …

Antisense oligonucleotide therapy for H3. 3K27M diffuse midline glioma

Q Zhang, L Yang, YH Liu, JE Wilkinson… - Science translational …, 2023 - science.org
Diffuse midline gliomas (DMGs) are pediatric high-grade brain tumors in the thalamus,
midbrain, or pons; the latter subgroup are termed diffuse intrinsic pontine gliomas (DIPG) …

[HTML][HTML] CAR T cells: engineered immune cells to treat brain cancers and beyond

Z Huang, S Dewanjee, P Chakraborty, NK Jha, A Dey… - Molecular cancer, 2023 - Springer
Malignant brain tumors rank among the most challenging type of malignancies to manage.
The current treatment protocol commonly entails surgery followed by radiotherapy and/or …

Immune checkpoint inhibition for pediatric patients with recurrent/refractory CNS tumors: a single institution experience

C Cacciotti, J Choi, S Alexandrescu… - Journal of Neuro …, 2020 - Springer
Introduction Immune checkpoint inhibition through PD-1 and CTLA-4 blockade has shown
efficacy in some adult malignancies and generated interest in pediatrics, including central …

Pharmacologic inhibition of lysine-specific demethylase 1 as a therapeutic and immune-sensitization strategy in pediatric high-grade glioma

CP Bailey, M Figueroa, A Gangadharan… - Neuro …, 2020 - academic.oup.com
Background Diffuse midline gliomas (DMG), including brainstem diffuse intrinsic pontine
glioma (DIPG), are incurable pediatric high-grade gliomas (pHGG). Mutations in the H3 …

[HTML][HTML] Nanoparticles for diagnosis and target therapy in pediatric brain cancers

C Guido, C Baldari, G Maiorano, A Mastronuzzi… - Diagnostics, 2022 - mdpi.com
Pediatric brain tumors represent the most common types of childhood cancer and novel
diagnostic and therapeutic solutions are urgently needed. The gold standard treatment …

LncRNAs and CircRNAs in cancer

X Yin, H Lin, L Lin, L Miao, J He, Z Zhuo - MedComm, 2022 - Wiley Online Library
It is well known that noncoding RNAs (ncRNAs) cannot encode proteins, but they can play
important regulatory roles in tumors by combining with proteins, RNAs, and DNAs. As more …

Immunotherapy for medulloblastoma: current perspectives

TF Kabir, CA Kunos, JL Villano… - ImmunoTargets and …, 2020 - Taylor & Francis
Background Immune-mediated therapies have transformed the treatment of metastatic
melanoma and renal, bladder, and both small and non-small cell lung carcinomas …

[HTML][HTML] Identification and targeting of mutant peptide neoantigens in cancer immunotherapy

DJ Verdon, MR Jenkins - Cancers, 2021 - mdpi.com
Simple Summary Cancerous cells acquire genetic mutations that can lead to changes in the
amino acid sequence of proteins. These altered amino acid sequences, or “neoantigens” …